HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,5,4'-trihydroxystilbene-4'-O-glucoside

has cardioprotective activity; structure in first source

Also Known As:

3,5,4'-trihydroxystilbene-4'-O-beta-D-glucoside; E.resveratroloside; resveratroloside

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - 3,5,4'-trihydroxystilbene-4'-O-glucoside: 3
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        Stilbenes: 657
        3,5,4'-trihydroxystilbene-4'-O-glucoside: 3

Experts

1.	Han, Hongping: 1 article (03/2019)
2.	Jiang, Sirong: 1 article (03/2019)
3.	Shao, Yun: 1 article (03/2019)
4.	Tao, Jihong: 1 article (03/2019)
5.	Wei, Wei: 1 article (03/2019)
6.	Yue, Huilan: 1 article (03/2019)
7.	Zhang, Ting: 1 article (03/2019)
8.	Zhao, Xiaohui: 1 article (03/2019)
9.	Zhou, Guoyin: 1 article (03/2019)
10.	Ferdous, Saba: 1 article (01/2015)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/01/2015 - "Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study."
2.	Diabetes Mellitus 03/13/2019 - "This study suggested that resveratroloside had the ability to regulate PBG levels and can be considered a potential agent for the treatment of diabetes mellitus."
3.	Myocardial Infarction 09/01/2013 - "It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). "
4.	Ischemia 09/01/2013 - "Cardioprotective effect of resveratrol and resveratroloside was determined in ischemia-reperfusion experiments on rats. " 09/01/2013 - "It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). "
5.	Hyperglycemia 03/13/2019 - "Resveratroloside Alleviates Postprandial Hyperglycemia in Diabetic Mice by Competitively Inhibiting α-Glucosidase."

Related Drugs and Biologics

1.	Phytochemicals
2.	Dopamine D3 Receptors
3.	Glycyrrhetinic Acid (Po 12)
4.	Glucosidases
5.	Resveratrol